AI is Accelerating Drug Discovery: McKernan

SV Health Investors’ Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery and improving patient selection for clinical trials. But McKernan says some parts of…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.